ArticleToxics2025
A Global Overview of Per- and Polyfluoroalkyl Substance Regulatory Strategies and Their Environmental Impact.
Article in Toxics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Advances in the application of assisted reproductive technology in fertility preservation for female patients with malignant tumours of the reproductive systems.Annals of medicine · 2026Review
- Investigation of the Effects of Perfluorooctane Sulfonic Acid (PFOS) and Perfluorooctanoic Acid (PFOA) Exposure on Interleukin-17 Signalling and Poly(I:C)-Induced Lung Inflammation in BALB/c Mice.Basic & clinical pharmacology & toxicology · 2026Article
- Association between serum perfluoroalkyl substances and COPD risk: population evidence and in vitro validation.BMC pulmonary medicine · 2026Article
- Global Disparities in the Regulation of PFASs: The Risk of Shifting the PFAS Pollution Burden to Developing Countries.Environmental science & technology · 2026Review
- Long-Term Per- and Polyfluoroalkyl Substances Exposure and Kidney Function in Taiwanese Adolescents and Young Adults: A 10-Year Prospective Cohort Study.Journal of xenobiotics · 2026Article
- PFAS exposure and reproductive dysfunction: implications for outcomes in assisted reproductive technologies.Frontiers in endocrinology · 2026Review
- Article
- Managing PFAS in Sewage Sludge: Exposure Pathways, Impacts, and Treatment Innovations.Journal of xenobiotics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Per- and polyfluoroalkyl substances (PFASs), while possessing desirable properties for human society, have increasingly raised concerns due to their environmental persistence, bioaccumulation, and ecotoxicity. One of the major challenges with PFASs is the inconsistent adoption of regulatory strategies by authorities across different countries and regions, making it difficult to address the issue on a global scale. To obtain a global overview of PFAS regulatory patterns, this study utilized the most recent PFAS regulatory databases across different jurisdictions, both local and global. Among all geographic regions, the United States Environmental Protection Agency (USEPA) and European Union (EU) Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) encompass the most jurisdictions for PFASs. However, most PFASs are without regulation under the current regulatory status. We also assessed the regulatory ecotoxicity status of PFASs under the Toxic Substances Control Act (TSCA) of the USEPA. The results showed that 36.3% of PFASs are of Unknown or Variable composition, Complex reaction products, or Biological materials (UVCB) and classified as E;P (persistent, bioaccumulative, and toxic), followed by 31.3% as P (persistent) and 13.2% as P;S (persistent and toxic). We highlight the regulatory patterns, industrial applications, and categorization of PFASs under different regulatory frameworks. The need for international cooperation and harmonized regulatory standards to mitigate PFAS pollution is also addressed. A coordinated effort involving regulatory agencies, industry, researchers, and the public will be essential to facilitate harmonized regulations of PFASs and ensure a sustainable and healthy environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.